Gallagher Cam — SEC Form 4 filings
SEC reporting owner CIK 1557832. 11 Form 4 filings on record with FilingPulse; latest filed 2026-09-08.
Transaction summary — filings shown
Covers all 11 filings on record, filed 2024-02-05 to 2026-09-08. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 2 legs across 1 filing — 164,000 shares, $323,693 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 3 legs across 3 filings — 22,322 shares, $261,701 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 14.
- Largest priced transaction: purchase of 83,000 shares @ $1.97 ($163,419) in Opus Genetics, Inc., filed 2025-12-31.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Opus Genetics, Inc. (IRD) | Director | 8 | 2 legs · 164,000 sh · $323,693 | — | 12 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | President, Interim CFO, Director | 3 | — | 3 legs · 22,322 sh · $261,701 | 2 |
Form 4 filings — Gallagher Cam
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-08 | 4 | Opus Genetics, Inc. (IRD) | Option exercise (M): 784,314 @ $1.15 · Option exercise (M): 784,314 (derivative) @ $0 | EDGAR |
| 2026-04-22 | 4 | Opus Genetics, Inc. (IRD) | Grant/award (A): 24,367 @ $0 | EDGAR |
| 2026-01-08 | 4 | Opus Genetics, Inc. (IRD) | Grant/award (A): 67,000 @ $0 | EDGAR |
| 2025-12-31 | 4 | Opus Genetics, Inc. (IRD) | Purchase (P): 81,000 @ $1.98 · Purchase (P): 83,000 @ $1.97 · Grant/award (A): 33,000 @ $0 | EDGAR |
| 2025-08-27 | 4 | Opus Genetics, Inc. (IRD) | Grant/award (A): 869,565 @ $1.15 | EDGAR |
| 2025-05-02 | 4 | Opus Genetics, Inc. (IRD) | Grant/award (A): 79,504 @ $0 · Grant/award (A): 79,592 (derivative) @ $0 | EDGAR |
| 2025-03-26 | 4 | Opus Genetics, Inc. (IRD) | Grant/award (A): 784,314 · Grant/award (A): 784,314 (derivative) | EDGAR |
| 2024-06-13 | 4 | Ocuphire Pharma, Inc. (OCUP) | Grant/award (A): 41,143 @ $0 · Grant/award (A): 35,181 (derivative) @ $0 | EDGAR |
| 2024-05-31 | 4 | Zentalis Pharmaceuticals, Inc. (ZNTL) | Sale (S): 9,597 @ $11.98 | EDGAR |
| 2024-02-12 | 4 | Zentalis Pharmaceuticals, Inc. (ZNTL) | Sale (S): 1,173 @ $11.44 | EDGAR |
| 2024-02-05 | 4 | Zentalis Pharmaceuticals, Inc. (ZNTL) | Grant/award (A): 192,500 @ $0 · Sale (S): 11,552 @ $11.54 · Grant/award (A): 192,500 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1557832 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →